Lv51
1250 积分 2024-04-09 加入
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target
1个月前
已完结
Discovery of potent, orally active compounds of tyrosine kinase and Serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays
1个月前
已完结
Advanced Delivery Strategies of Nintedanib for Lung Disorders and Beyond: A Comprehensive Review
1个月前
已完结
Brief Report: Successful Pregnancy and Healthy Baby Outcome in a TKI-refractory ALK+ NSCLC Patient with CNS Metastasis Treated with Lorlatinib with Maternal-fetal Pharmacokinetics and Child Milestone Development Correlations
1个月前
已完结
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapies
1个月前
已完结
Anlotinib versus placebo as adjuvant therapy for localized high-grade soft tissue sarcomas: a phase 2, double-blinded, randomized controlled trial
3个月前
已完结
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
4个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
5个月前
已完结
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
5个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
5个月前
已完结
皖公网安备34019202002308
